Mondrian Investment Partners portfolio
Investment firmPortfolio as of Sep 30, 2026 (Q3 2026) · filed with the SEC on Oct 23, 2026 · data updated on Nov 5, 2026 · Q3 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Mondrian Investment Partners reported a $5.4 bn portfolio of 136 positions to the SEC as of the end of Q3 2026. Its largest positions are YUMC, SONY, LYG. During the quarter it opened Haleon.
Sections with a free account
What changed this quarter
106 positions with a change (20 new, 20 added to, 61 trimmed, 5 sold). 12 are listed here: those of 0.5 points of the portfolio or more (up to 12).
- Haleon+2.4 ppof portfolioNew— → 2.9%
- Merck−60%fewer sharesReduced2.9% → 1.6%
- Thermo Fisher Scientific−55%fewer sharesReduced2.7% → 2.0%
- Microsoft−43%fewer sharesReduced3.0% → 2.8%
- Charles Schwab−47%fewer sharesReduced2.6% → 1.8%
- Alphabet−46%fewer sharesReduced3.0% → 1.9%
- Salesforce−47%fewer sharesReduced1.6% → 1.5%
- Texas Instruments−48%fewer sharesReduced2.4% → 1.4%
- Meta Platforms−44%fewer sharesReduced1.8% → 1.6%
- Yum China Holdings−6.9%fewer sharesReduced14.3% → 16.2%
- Dollar Tree−49%fewer sharesReduced2.1% → 1.2%
- Bank of America−46%fewer sharesReduced2.1% → 1.3%
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- Yum China HoldingsYUMC16.2%
- Sony GroupSONY5.5%
- Lloyds Banking GroupLYG4.9%
- Banco SantanderSAN4.8%
- GSKGSK4.4%
- British American Tobacco p.l.c.BTI4.4%
- SanofiSNY4.3%
- Koninklijke PhilipsPHG3.6%
- BPBP3.2%
- Petrobras - Petroleo BrasileiroPBR3.1%
- HaleonHLN2.9%
- MicrosoftMSFT2.8%
- ShellSHEL2.3%
- VALEVALE2.1%
- Thermo Fisher ScientificTMO2.0%
“Since”: first quarter of the current run, unbroken until today. In the details, prices are the quarter-end prices of the quarters in which it added shares, per the 13F. The manager may have bought at any price within each quarter; the SEC only publishes the value at quarter end.
Portfolio by sector
- ● Consumer Discretionary 22%
- ● Health Care 18%
- ● Financials 17%
- ● Information Technology 11%
- ● Consumer Staples 10%
- ● Energy 10%
- ● Communication Services 4%
- ● Materials 3%
- ● Industrials 2%
- ● Real Estate 1%
- ● No sector 1%
How its portfolio changed (8 quarters)
Q3 2026: 136
Q3 2026: 55%
Q3 2026: 14.7%
Traded turnover: the weight it bought plus the weight it sold in the quarter, divided by two, excluding price moves. The plain “turnover” in the header does include that effect. With a free account: the full history and sectors over time.
13F filings with amendments or confidential positions
- 13F Q4 2024 ↗filed Feb 10, 2025Amendment of Feb 13, 2025 (replaces the original) ↗
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Investment firm, per its Form ADV of Apr 1, 2026 (medium confidence).
The data, as reported: MONDRIAN INVESTMENT PARTNERS LIMITED (CRD 107432): Institutional mandates; 5.D assets by client type: governments 50%, registered funds 19%, pooled vehicles 16%, pension plans 10% (of $49.3 bn); 5.F 118 accounts, 0% non-discretionary; 5.D 136 clients, 0 individuals
The type comes from a rule applied to that data. If it looks wrong, tell us.
Not counted as a concentrated manager: its portfolio is not within 5 to 100 positions. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided
Similar managers by type and size
Same type of filer and a 13F portfolio value between a third and three times this one. It is not a comparison of what they hold.
- Baupost GroupInvestment firm · $5.4 bn
- Resolution CapitalInvestment firm · $5.4 bn
- Paradigm Biocapital AdvisorsInvestment firm · $5.3 bn
- Abrams Capital ManagementInvestment firm · $5.5 bn
- Veritas Asset Management LLPInvestment firm · $5.6 bn
- ValueAct HoldingsInvestment firm · $5.6 bn